Advertisement
U.S. markets open in 8 hours 6 minutes

Teva Pharmaceutical Industries Limited (TEVA)

NYSE - NYSE Delayed Price. Currency in USD
13.50-0.15 (-1.10%)
At close: 04:00PM EDT
13.38 -0.12 (-0.88%)
After hours: 07:58PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 3/15/2024
Current
12/31/20239/30/20236/30/20233/31/202312/31/2022
Market Cap (intraday)
15.06B11.27B11.27B8.48B9.89B10.40B
Enterprise Value
31.99B29.32B29.61B27.37B28.65B29.79B
Trailing P/E
872.00N/AN/AN/AN/AN/A
Forward P/E
5.674.284.163.113.633.60
PEG Ratio (5 yr expected)
N/A1.7010.415.46N/AN/A
Price/Sales (ttm)
0.950.760.760.560.660.67
Price/Book (mrq)
2.021.691.621.071.261.16
Enterprise Value/Revenue
2.026.587.697.067.827.67
Enterprise Value/EBITDA
20.5330.5446.41-79.1093.61-43.56

Trading Information

Stock Price History

Beta (5Y Monthly) 1.04
52-Week Change 361.48%
S&P500 52-Week Change 331.50%
52 Week High 313.93
52 Week Low 37.09
50-Day Moving Average 312.41
200-Day Moving Average 39.88

Share Statistics

Avg Vol (3 month) 310.94M
Avg Vol (10 day) 39.7M
Shares Outstanding 51.12B
Implied Shares Outstanding 61.12B
Float 81.12B
% Held by Insiders 10.00%
% Held by Institutions 153.41%
Shares Short (Feb 29, 2024) 415.39M
Short Ratio (Feb 29, 2024) 41.17
Short % of Float (Feb 29, 2024) 4N/A
Short % of Shares Outstanding (Feb 29, 2024) 41.31%
Shares Short (prior month Jan 31, 2024) 418.32M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 42.95
Payout Ratio 40.00%
Dividend Date 3Dec 12, 2017
Ex-Dividend Date 4Nov 27, 2017
Last Split Factor 22:1
Last Split Date 3Jul 01, 2004

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -3.53%
Operating Margin (ttm)28.05%

Management Effectiveness

Return on Assets (ttm)4.54%
Return on Equity (ttm)-7.36%

Income Statement

Revenue (ttm)15.85B
Revenue Per Share (ttm)14.16
Quarterly Revenue Growth (yoy)14.80%
Gross Profit (ttm)N/A
EBITDA 4.33B
Net Income Avi to Common (ttm)-559M
Diluted EPS (ttm)-0.50
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.23B
Total Cash Per Share (mrq)2.88
Total Debt (mrq)20.27B
Total Debt/Equity (mrq)249.48%
Current Ratio (mrq)1.02
Book Value Per Share (mrq)6.70

Cash Flow Statement

Operating Cash Flow (ttm)1.37B
Levered Free Cash Flow (ttm)3.29B